Conditions

Focus on cancer in scleroderma at ACR23

AS biosimilars script approval goes online

RA Clinical Care Standard launched

‘The P in prednisone stands for poison’

New First Nations resources for OA, RA, SLE and gout

‘Concerned’: dermatologists respond to NSW pharmacy trial

SpA highlights from ACR23

MHT can increase late onset RA risk, even for former users
